Annual Total Liabilities
$851.50 K
-$2.61 M-75.39%
December 31, 2023
Summary
- As of February 25, 2025, GDTC annual total liabilities is $851.50 thousand, with the most recent change of -$2.61 million (-75.39%) on December 31, 2023.
- During the last 3 years, GDTC annual total liabilities has fallen by -$1.67 million (-66.26%).
- GDTC annual total liabilities is now -75.39% below its all-time high of $3.46 million, reached on December 31, 2022.
Performance
GDTC Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$551.80 K
-$299.70 K-35.20%
June 30, 2024
Summary
- As of February 25, 2025, GDTC quarterly total liabilities is $551.80 thousand, with the most recent change of -$299.70 thousand (-35.20%) on June 30, 2024.
- Over the past year, GDTC quarterly total liabilities has stayed the same.
- GDTC quarterly total liabilities is now -84.05% below its all-time high of $3.46 million, reached on December 31, 2022.
Performance
GDTC Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
GDTC Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -75.4% | 0.0% |
| 3 y3 years | -66.3% | 0.0% |
| 5 y5 years | -66.3% | 0.0% |
GDTC Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.4% | at low | -84.0% | +0.3% |
| 5 y | 5-year | -75.4% | at low | -84.0% | +0.3% |
| alltime | all time | -75.4% | at low | -84.0% | +0.3% |
CytoMed Therapeutics Limited Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $551.80 K(-35.2%) |
| Dec 2023 | $851.50 K(-75.4%) | $851.50 K(+54.8%) |
| Jun 2023 | - | $550.10 K(-84.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $3.46 M(+34.0%) | $3.46 M(+34.1%) |
| Jun 2022 | - | $2.58 M(-0.0%) |
| Dec 2021 | $2.58 M(+2.3%) | $2.58 M |
| Dec 2020 | $2.52 M | - |
FAQ
- What is CytoMed Therapeutics Limited annual total liabilities?
- What is the all time high annual total liabilities for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual total liabilities year-on-year change?
- What is CytoMed Therapeutics Limited quarterly total liabilities?
- What is the all time high quarterly total liabilities for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited quarterly total liabilities year-on-year change?
What is CytoMed Therapeutics Limited annual total liabilities?
The current annual total liabilities of GDTC is $851.50 K
What is the all time high annual total liabilities for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual total liabilities is $3.46 M
What is CytoMed Therapeutics Limited annual total liabilities year-on-year change?
Over the past year, GDTC annual total liabilities has changed by -$2.61 M (-75.39%)
What is CytoMed Therapeutics Limited quarterly total liabilities?
The current quarterly total liabilities of GDTC is $551.80 K
What is the all time high quarterly total liabilities for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high quarterly total liabilities is $3.46 M
What is CytoMed Therapeutics Limited quarterly total liabilities year-on-year change?
Over the past year, GDTC quarterly total liabilities has changed by $0.00 (0.00%)